About MITRO

Company Profile

Management Team

Evolution

News

Exhibition | Mitro invites you to the 2025 DIA China Annual Meeting

Exhibition | Mitro invites you to the 2025 DIA China Annual Meeting

2025-05-07

May 22-25, 2025, Shanghai Zhangjiang Science Hall, booth Z05, looking forward to seeing you there!

MITRO Achieves AAALAC Full Accreditation for the Third Time

MITRO Achieves AAALAC Full Accreditation for the Third Time

2025-03-24

Annual Inspection of Jiangsu Province Laboratory Animal License

Annual Inspection of Jiangsu Province Laboratory Animal License

2025-01-23

Exhibition | Mitro will soon participate in the SNMMI 2024 Annual Meeting

Exhibition | Mitro will soon participate in the SNMMI 2024 Annual Meeting

2024-04-30

The 2024 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) will be held from June 8-11, 2024, in Toronto, Canada. The SNMMI Annual Meeting is recognized as the premier educational, scientific, research, and networking event in the field of nuclear medicine and molecular imaging, attracting thousands of professionals from around the world each year.

Annual Inspection of Jiangsu Province Laboratory Animal License

Annual Inspection of Jiangsu Province Laboratory Animal License

2024-03-20

Annual Inspection Report of Laboratory Animal License in Jiangsu Province

Radiopharmaceutical CRDMO MITRO Has Raised Nearly 400 Million Yuan to Support the Development of Innovative Drugs!

Radiopharmaceutical CRDMO MITRO Has Raised Nearly 400 Million Yuan to Support the Development of Innovative Drugs!

2024-03-18

On March 18, 2024, Yantai Dongcheng Pharmaceutical Group Co., Ltd. announced that it agreed to increase the capital and shares of its subsidiary MITRO (Yantai) Biotech Co., Ltd. (hereinafter referred to as "MITRO" or "the company"), which will be led by SDIC investment promotion, SDIC cohesion and Shandong local industrial fund, etc., with a total financing of nearly 400 million yuan.

< 12 >